REG - hVIVO plc - Result of AGM <Origin Href="QuoteRef">HVO.L</Origin>

hVIVOAnnouncement

23/05/2016 12:00

RNS Number : 0179Z
hVIVO plc
23 May 2016
For immediate release 12.00pm: 23 May 2016
HVIVO PLC
("hVIVO" or the "Company")
Result of Annual General Meeting
hVIVO plc (AIM: RVG), the pioneer of human models of disease, is pleased to announce that all resolutions proposed at its Annual General Meeting, held at 10.00am on 23 May 2016, were duly passed.
For further information please contact:
hVIVO plc+44 207 756 1300
Kym Denny (Chief Executive Officer)
Graham Yeatman (Chief Financial & Business Officer) 
Media Enquiries+44 203 021 3933 / +44 7854 979 420
Colin Paterson (Director of Marketing, Communication and Public Relations)
 
Numis Securities Limited +44 207 260 1000 
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
Notes to Editors:
hVIVO plc ("hVIVO") is a life sciences company pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, RSV, asthma and common cold. hVIVO has commercialised four disease models, successfully enrolled over 2,000 subjects and conducted over 40 product validation studies for a wide range of industry, government and academic clients and collaborators.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RAGAKNDNKBKDQPB